| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kelsey Poisson, Matthew Wong, Chon Lee, Maria Roberta Cili. Response to cannabidiol in epilepsy of infancy with migrating focal seizures associated with KCNT1 mutations: An open-label, prospective, interventional study. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. vol 25. 2020-08-17. PMID:31926846. |
response to cannabidiol in epilepsy of infancy with migrating focal seizures associated with kcnt1 mutations: an open-label, prospective, interventional study. |
2020-08-17 |
2023-08-13 |
Not clear |
| Kelsey Poisson, Matthew Wong, Chon Lee, Maria Roberta Cili. Response to cannabidiol in epilepsy of infancy with migrating focal seizures associated with KCNT1 mutations: An open-label, prospective, interventional study. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. vol 25. 2020-08-17. PMID:31926846. |
cannabidiol (cbd) has recently arisen in public interest due to its potential in treatment-resistant epilepsies as demonstrated in randomized controlled trials for dravet syndrome and lennox-gastaut syndrome. |
2020-08-17 |
2023-08-13 |
Not clear |
| Catherine Chiro. Stiripentol for the treatment of seizures associated with Dravet syndrome. Expert review of neurotherapeutics. vol 19. issue 4. 2020-08-10. PMID:30900478. |
therapeutic options recently grew in this rare and severe early-onset epilepsy with the approval of stiripentol and cannabidiol in 2018 in the us and the positive trials just completed with fenfluramine. |
2020-08-10 |
2023-08-13 |
Not clear |
| George Sam Wang, David W A Bourne, Jost Klawitter, Cristina Sempio, Kevin Chapman, Kelly Knupp, Michael F Wempe, Laura Borgelt, Uwe Christians, Kennon Heard, Lalit Baja. Disposition of oral delta-9 tetrahydrocannabinol (THC) in children receiving cannabis extracts for epilepsy. Clinical toxicology (Philadelphia, Pa.). vol 58. issue 2. 2020-08-04. PMID:31111749. |
disposition of oral delta-9 tetrahydrocannabinol (thc) in children receiving cannabis extracts for epilepsy. |
2020-08-04 |
2023-08-13 |
Not clear |
| Juan Pablo Appendino, Cyrus Boelman, Paula M Brna, Jorge G Burneo, Curtis S Claassen, Mary B Connolly, Michael V T De Guzman, Paolo Federico, Deirdre Floyd, Richard James Huntsman, Manouchehr Javidan, Nathalie Jette, Laura L Jurasek, Mark R Keezer, Jonathan C Lau, Bláthnaid McCoy, Richard S McLachlan, Marcus C Ng, Dang Khoa Nguyen, Aylin Y Reid, Jong M Rho, O Carter Snead, José F Téllez-Zenteno, Laura Wang, Maria Martha Za. Position Statement on the Use of Medical Cannabis for the Treatment of Epilepsy in Canada. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. vol 46. issue 6. 2020-08-04. PMID:31466531. |
position statement on the use of medical cannabis for the treatment of epilepsy in canada. |
2020-08-04 |
2023-08-13 |
Not clear |
| Juan Pablo Appendino, Cyrus Boelman, Paula M Brna, Jorge G Burneo, Curtis S Claassen, Mary B Connolly, Michael V T De Guzman, Paolo Federico, Deirdre Floyd, Richard James Huntsman, Manouchehr Javidan, Nathalie Jette, Laura L Jurasek, Mark R Keezer, Jonathan C Lau, Bláthnaid McCoy, Richard S McLachlan, Marcus C Ng, Dang Khoa Nguyen, Aylin Y Reid, Jong M Rho, O Carter Snead, José F Téllez-Zenteno, Laura Wang, Maria Martha Za. Position Statement on the Use of Medical Cannabis for the Treatment of Epilepsy in Canada. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. vol 46. issue 6. 2020-08-04. PMID:31466531. |
this policy change along with recent publications evaluating the efficacy of cannabis for the medical treatment of epilepsy and media awareness about its use have increased the public interest about this agent. |
2020-08-04 |
2023-08-13 |
Not clear |
| Juan Pablo Appendino, Cyrus Boelman, Paula M Brna, Jorge G Burneo, Curtis S Claassen, Mary B Connolly, Michael V T De Guzman, Paolo Federico, Deirdre Floyd, Richard James Huntsman, Manouchehr Javidan, Nathalie Jette, Laura L Jurasek, Mark R Keezer, Jonathan C Lau, Bláthnaid McCoy, Richard S McLachlan, Marcus C Ng, Dang Khoa Nguyen, Aylin Y Reid, Jong M Rho, O Carter Snead, José F Téllez-Zenteno, Laura Wang, Maria Martha Za. Position Statement on the Use of Medical Cannabis for the Treatment of Epilepsy in Canada. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. vol 46. issue 6. 2020-08-04. PMID:31466531. |
the canadian league against epilepsy medical therapeutics committee, along with a multidisciplinary group of experts and canadian epilepsy alliance representatives, has developed a position statement about the use of medical cannabis for epilepsy. |
2020-08-04 |
2023-08-13 |
Not clear |
| R Van Rensburg, V Pillay-Fuentes Lorente, M Blockman, K Moodley, J M Wilmshurst, E H Decloed. Medical cannabis: What practitioners need to know. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. vol 110. issue 3. 2020-07-30. PMID:32657695. |
adjuvant therapy with medical cannabis can reduce seizure frequency for lennox-gastaut syndrome and dravet syndrome by 18.8% and 22.8%, respectively, and may be beneficial for other rare forms of epilepsy. |
2020-07-30 |
2023-08-13 |
Not clear |
| L Ha. Understanding the basics of cannabidiol from cannabis to apply to therapeutics in epilepsy. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. vol 110. issue 2. 2020-07-28. PMID:32657678. |
understanding the basics of cannabidiol from cannabis to apply to therapeutics in epilepsy. |
2020-07-28 |
2023-08-13 |
Not clear |
| L Ha. Understanding the basics of cannabidiol from cannabis to apply to therapeutics in epilepsy. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. vol 110. issue 2. 2020-07-28. PMID:32657678. |
cannabidiol (cbd) is one of the main compounds in cannabis plants, and there is evidence that it can successfully treat certain patients with epilepsy. |
2020-07-28 |
2023-08-13 |
Not clear |
| Roy C Martin, Tyler E Gaston, Matthew Thompson, Steve B Ampah, Gary Cutter, E Martina Bebin, Jerzy P Szaflarsk. Cognitive functioning following long-term cannabidiol use in adults with treatment-resistant epilepsy. Epilepsy & behavior : E&B. vol 97. 2020-07-23. PMID:31220785. |
cognitive functioning following long-term cannabidiol use in adults with treatment-resistant epilepsy. |
2020-07-23 |
2023-08-13 |
human |
| Roy C Martin, Tyler E Gaston, Matthew Thompson, Steve B Ampah, Gary Cutter, E Martina Bebin, Jerzy P Szaflarsk. Cognitive functioning following long-term cannabidiol use in adults with treatment-resistant epilepsy. Epilepsy & behavior : E&B. vol 97. 2020-07-23. PMID:31220785. |
recently, cannabidiol (cbd) has demonstrated efficacy in epilepsy treatment. |
2020-07-23 |
2023-08-13 |
human |
| Randi von Wrede, Susanna Moskau-Hartmann, Nicola Amarell, Christian Erich Elger, Christoph Helmstaedte. Knowledge, expectations and fears of cannabis use of epilepsy patients at a tertiary epilepsy center. Epilepsy & behavior : E&B. vol 99. 2020-07-20. PMID:31419634. |
knowledge, expectations and fears of cannabis use of epilepsy patients at a tertiary epilepsy center. |
2020-07-20 |
2023-08-13 |
Not clear |
| Linda C Laux, E Martina Bebin, Daniel Checketts, Michael Chez, Robert Flamini, Eric D Marsh, Ian Miller, Kathryn Nichol, Yong Park, Eric Segal, Laurie Seltzer, Jerzy P Szaflarski, Elizabeth A Thiele, Arie Weinstoc. Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results. Epilepsy research. vol 154. 2020-07-13. PMID:31022635. |
since 2014, patients with severe treatment-resistant epilepsies (tres) have been receiving add-on cannabidiol (cbd) in an ongoing, expanded access program (eap), which closely reflects clinical practice. |
2020-07-13 |
2023-08-13 |
Not clear |
| Alysse Kerr, Victoria Walston, Victoria S S Wong, Marissa Kellogg, Lia Erns. Marijuana use among patients with epilepsy at a tertiary care center. Epilepsy & behavior : E&B. vol 97. 2020-07-13. PMID:31252269. |
the expansion of medical and recreational marijuana legalization facilitates patient access to cannabis, and many patients with epilepsy pursue marijuana as a treatment for seizures. |
2020-07-13 |
2023-08-13 |
human |
| Alysse Kerr, Victoria Walston, Victoria S S Wong, Marissa Kellogg, Lia Erns. Marijuana use among patients with epilepsy at a tertiary care center. Epilepsy & behavior : E&B. vol 97. 2020-07-13. PMID:31252269. |
the majority of respondents (n = 39) reported cannabis use for the purpose of treating epilepsy (87.2%, n = 34), and strongly agreed (53.8%, n = 21) or agreed (28.2%, n = 11) that cannabis use improved seizure control. |
2020-07-13 |
2023-08-13 |
human |
| Alysse Kerr, Victoria Walston, Victoria S S Wong, Marissa Kellogg, Lia Erns. Marijuana use among patients with epilepsy at a tertiary care center. Epilepsy & behavior : E&B. vol 97. 2020-07-13. PMID:31252269. |
further research is needed to understand recreational cannabis use among patients with epilepsy while clinical research for pharmaceutical cannabis products continues. |
2020-07-13 |
2023-08-13 |
human |
| Alexis Mitelpunkt, Uri Kramer, Moran Hausman Kedem, Efrat Zilbershot Fink, Rotem Orbach, Veronika Chernuha, Aviva Fattal-Valevski, Lisa Deutsch, Daphna Heffetz, Hagit Sack. The safety, tolerability, and effectiveness of PTL-101, an oral cannabidiol formulation, in pediatric intractable epilepsy: A phase II, open-label, single-center study. Epilepsy & behavior : E&B. vol 98. issue Pt A. 2020-07-08. PMID:31394352. |
the safety, tolerability, and effectiveness of ptl-101, an oral cannabidiol formulation, in pediatric intractable epilepsy: a phase ii, open-label, single-center study. |
2020-07-08 |
2023-08-13 |
Not clear |
| Tyler E Gaston, Magdalena Szaflarski, Barbara Hansen, E Martina Bebin, Jerzy P Szaflarsk. Quality of life in adults enrolled in an open-label study of cannabidiol (CBD) for treatment-resistant epilepsy. Epilepsy & behavior : E&B. vol 95. 2020-07-01. PMID:31003195. |
quality of life in adults enrolled in an open-label study of cannabidiol (cbd) for treatment-resistant epilepsy. |
2020-07-01 |
2023-08-13 |
human |
| Stephanie McGrath, Lisa R Bartner, Sangeeta Rao, Rebecca A Packer, Daniel L Gustafso. Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy. Journal of the American Veterinary Medical Association. vol 254. issue 11. 2020-07-01. PMID:31067185. |
randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy. |
2020-07-01 |
2023-08-13 |
Not clear |